New-onset chronic musculoskeletal pain following COVID-19 infection fulfil the Fibromyalgia clinical syndrome criteria


Omar Khoja, Matthew Mulvey, Sarah Astill,  et. al. doi: https://doi.org/10.1101/2024.07.10.24310234 Abstract Background: New-onset chronic musculoskeletal (MSK) pain (> 3 months duration) is one of the commonest persistent symptoms of Post-COVID syndrome (PCS). There is emerging evidence that the chronic MSK pain and associated symptoms in PCS have similarities to Fibromyalgia Syndrome (FMS). This study aimed to characterise PCS related new-onset chronic MSK […]

Kansas City Attorney General’s legal report on the case against Pfizer


BY CARL HENEGHAN, 2024  PHARMA, VACCINES   We’ve extracted the main points from the Kansas City Attorney General’s legal report on the case against Pfizer that we first mentioned in Due Process—all quotes are taken verbatim. This is a lengthy post, and we’d recommend having an anger management strategy to hand while reading. If you are making a comment, […]

Study Reveals Why COVID-19 Vaccine Antibodies Wane Rapidly


Authored by Marina Zhang via The Epoch Times Research led by scientists at Emory University in Atlanta found that while tetanus and influenza vaccines prompt the body to produce long-lived plasma cells that generate antibodies, COVID-19 vaccines do not. The study may explain why antibody protection from COVID-19 mRNA vaccines wanes so rapidly. The mRNA […]

Cutting Edge: Hyperinflammatory Monocytes Expressing CD56 Abound in Severe COVID-19 Patients 


Stefania Campana; Claudia De Pasquale; Giacomo Sidoti Migliore;, et. al. J Immunol (2022) 209 (4): 655–659. https://doi.org/10.4049/jimmunol.2200021 Abstract Proinflammatory monocytes play a preponderant role in the development of a cytokine storm causing fatal consequences in coronavirus disease 2019 (COVID-19) patients, highlighting the importance of analyzing in more detail monocyte distribution in these patients. In this study, […]

What Does Recovery From COVID-19 Look Like?


By Colleen Doherty, MD, 2024, Medically reviewed by Renee Nilan, MD, Very Well Health COVID-19—an infection caused by the SARS-CoV-2 virus—first appeared in late 2019 and can manifest in several ways, ranging from no or mild symptoms to severe or critical illness. While most people with COVID-19 fully recover, the timeline for this recovery process varies. Also, […]

American People May Finally Know COVID Origins With Trump In Office


Despite Covid-19 killing 1.2 million Americans and unleashing $18 trillion in economic damages on the US economy, the origins of the virus have yet to be officially disclosed to the American public by regulators, policymakers, and public health officials. Corporate mainstream media, Washington elite swamp creatures, intelligence agencies, and Big Tech unleashed a censorship cartel in a multi-year […]

The long arm of COVID


Fatigue, brain fog and other symptoms continue to plague more than 5% of Wisconsin residents BY MEL HAMMOND , JULY 9, 2024 Autumn Bonner struggled with long COVID symptoms for a year and a half before a diagnosis. Fatigue, brain fog and other symptoms continue to plague more than 5% of Wisconsin residents “It was like somebody […]

New Report Reviews Evidence on Long COVID Diagnosis, Risk, Symptoms, and Functional Impact for Patients


June 5, 2024 WASHINGTON — A new report from the National Academies of Sciences, Engineering, and Medicine presents conclusions about Long COVID diagnosis, symptoms, and impact on daily function — including that Long COVID can cause more than 200 symptoms, and that a positive COVID-19 test is not necessary to make a Long COVID diagnosis.  Since the […]

Had COVID? You’ll probably make antibodies for a lifetime


People who recover from mild COVID-19 have bone-marrow cells that can churn out antibodies for decades, although viral variants could dampen some of the protection they offer. Authors: Ewen Callaway Journal: NATURE Many people who have been infected with SARS-CoV-2 will probably make antibodies against the virus for most of their lives. So suggest researchers […]